Figure 1.
17β-estradiol enhances conduit PA vasoreactivity in PAH. (A) Dose-dependent response to receptor-independent vasoconstrictor KCl and (B) pressure-dependence of functional contraction ratio at 50 mM KCl.
17β-estradiol enhances conduit PA vasoreactivity in PAH. (A) Dose-dependent response to receptor-independent vasoconstrictor KCl and (B) pressure-dependence of functional contraction ratio at 50 mM KCl.